Informing the Investigator: Implementing an Automated SUSAR System

In this webinar, the challenge of the prompt reporting of a low or high number of SUSARs to Investigators in global and large-scale clinical trials will be addressed. Additionally, the speaker, Dr. Max Horneck, CEO, maxclinical GmbH, will outline a real-life implementation of a secure communication platform for SUSAR reporting in a mid-size pharmaceutical company.

20 November 2014